ТОО "DONIOR IBD MR"
This is a company preview
Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.
Risks
0/17Комитет государственных доходов · Государственные закупки РК · АО ФНБ «Самрук-Казына» · АОО «НИШ»This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.
Procurement signals
Court cases
Arrests & encumbrances
Enforcement proceedings
Certificates
Licenses
Summary
Министерство юстиции РКActivities
1ОКЭДПредоставление прочих индивидуальных услуг, не включенных в другие группировки
Contacts
Change history
Financial statements
PremiumPublic contracts
What it sells and where
Samruk-Kazyna procurement
Tender bids
Procurement as a customer
Assets
Bank accounts
Leadership
1- ИД
Ибодуллаев Дониёр Бахтиярович
Director
Founders
Accreditations
Employees
Affiliated companies
PremiumDirector's involvement in other legal entities
Branches
Company networks
PremiumSimilar companies
Media mentions
Company summary
ТОО "DONIOR IBD MR" (BIN 250140024685) is an active legal entity in Мангистауская область, registered in 2025 (1 year on the market). Primary activity — предоставление прочих индивидуальных услуг, не включенных в другие группировки. Automated screening of open registries found no risk indicators for "DONIOR IBD MR". Director on record — Ибодуллаев Дониёр Бахтиярович. Data current as of November 6, 2026.
Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.